GalR1, but not GalR2 or GalR3, levels are regulated by galanin signaling in the locus coeruleus through a cyclic AMP-dependent mechanism

Journal of Neurochemistry

Volumn 93, Issue 5, 2005, Pages 1168-1176

  Hawes, Jessica J ^a   Brunzell, Darlene H ^a   Wynick, David ^b   Zachariou, Venetia ^c   Picciotto, Marina R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF CRETE   (Greece)

Author keywords

Knockout mice; Negative feedback; Norepinephrine; Tyrosine hydroxylase

Indexed keywords

CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GALANIN; GALANIN RECEPTOR 1; GALANIN RECEPTOR 2; GALANIN RECEPTOR 3; MESSENGER RNA; NORADRENALIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ARTICLE; BRAIN; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; NORADRENERGIC SYSTEM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; CELL LINE; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; FEEDBACK, BIOCHEMICAL; GALANIN; LOCUS COERULEUS; MALE; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; RECEPTOR, GALANIN, TYPE 1; RECEPTOR, GALANIN, TYPE 2; RECEPTOR, GALANIN, TYPE 3; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 20144362210     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03105.x     Document Type: Article

References (52)

1. Aston-Jones G., Hirata H. and Akaoka H. (1997) Local opiate withdrawal in locus coeruleus in vivo. Brain Res. 765, 331-336.
2. Baraban S. C., Lothman E. W., Lee A. and Guyenet P. G. (1995) Kappa opioid receptor-mediated suppression of voltage-activated potassium current in a catecholaminergic neuronal cell line. J. Pharmacol. Exp. Ther. 273, 927-933.
3. Boundy V. A., Chen J. and Nestler E. J. (1998) Regulation of cAMP-dependent protein kinase subunit expression in CATH.nd SH-SY5Y cells. J. Pharmacol. Exp. Ther. 286, 1058-1065.
4. Burazin T. C. and Gundlach A. L. (1998) Inducible galanin and GalR2 receptor system in motor neuron injury and regeneration. J. Neurochem. 71, 879-882.
5. Burazin T. C., Larm J. A. and Gundlach A. L. (2001) Regulation by osmotic stimuli of galanin-R1 receptor expression in magnocellular neurones of the paraventricular and supraoptic nuclei of the rat. J. Neuroendocrinol. 13, 358-370.
6. Carter D. A. and Murphy D. (1989) Cyclic nucleotide dynamics in the rat hypothalamus during osmotic stimulation: in vivo and in vitro studies. Brain Res. 487, 350-356.
7. Chao J. and Nestler E. J. (2004) Molecular neurobiology of drug addiction. Annu. Rev. Med. 55, 113-132.
8. Duman R. S., Tallman J. F. and Nestler E. J. (1988) Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus. J. Pharmacol. Exp. Ther. 246, 1033-1039.
9. Gonzalez G. A. and Montminy M. R. (1989) Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59, 675-680.
10. Guitart X., Thompson M. A., Mirante C. K., Greenberg M. E. and Nestler E. J. (1992) Regulation of cyclic AMP response element-binding protein (CREB) phosphorylation by acute and chronic morphine in the rat locus coeruleus. J. Neurochem. 58, 1168-1171.
11. Hawes J. J. and Picciotto M. R. (2004) Characterization of GalR1, GalR2, and GalR3 immunoreactivity in catecholaminergic nuclei of the mouse brain. J. Comp. Neurol. 479, 410-423.
12. Herz A. (1983) Multiple opiate receptors and their functional significance. J. Neural Transm. Suppl. 18, 227-233.
13. Hohmann J. G., Jureus A., Teklemichael D. N., Matsumoto A. M., Clifton D. K. and Steiner R. A. (2003) Distribution and regulation of galanin receptor 1 messenger RNA in the forebrain of wild type and galanin-transgenic mice. Neuroscience 117, 105-117.
14. Howard A. D., Tan C., Shiao L. L. et al. (1997) Molecular cloning and characterization of a new receptor for galanin. FEBS Lett. 405, 285-290.
15. Ivanov A. and Aston-Jones G. (2001) Local opiate withdrawal in locus coeruleus neurons in vitro. J. Neurophysiol. 85, 2388-2397.
16. Johannessen M., Delghandi M. P. and Moens U. (2004) What turns CREB on? Cell Signal 16, 1211-1227.
17. Kolakowski L. F. Jr, O'Neill G. P., Howard A. D. (1998) Molecular characterization and expression of cloned human galanin receptors GALR2 and GALR3. J. Neurochem. 71, 2239-2251.
18. Kunkler P. E., Wang G. M. and Hwang B. H. (1994) Galanin-containing neurons in the solitary nucleus and locus coeruleus of spontaneously hypertensive rats are associated with genetic hypertension. Brain Res. 651, 349-352.
19. Maldonado R., Valverde O., Garbay C. and Roques B. P. (1995) Protein kinases in the locus coeruleus and periaqueductal gray matter are involved in the expression of opiate withdrawal. Naunyn Schmiedebergs Arch. Pharmacol. 352, 565-575.
20. Mennicken F., Hoffert C., Pelletier M., Ahmad S. and O'Donnell D. (2002) Restricted distribution of galanin receptor 3 (GalR3) mRNA in the adult rat central nervous system. J. Chem. Neuroanat. 24, 257-268.
21. Miller M. A., Kolb P. E., Leverenz J. B., Peskind E. R. and Raskind M. A. (1999) Preservation of noradrenergic neurons in the locus ceruleus that coexpress galanin mRNA in Alzheimer's disease. J. Neurochem. 73, 2028-2036.
22. Mounier F., Bluet-Pajot M. T., Moinard F., Kordon C. and Epelbaum J. (1996) Activation of locus coeruleus somatostatin receptors induces an increase of growth hormone release in male rats. J. Neuroendocrinol. 8, 761-764.
23. Nestler E. J. (2004) Historical review: molecular and cellular mechanisms of opiate and cocaine addiction. TRENDS Pharmacol. Sci. 25, 210-218.
24. Nestler E. J. and Greengard P. (1983) Protein phosphorylation in the brain. Nature 305, 583-588.
25. Nestler E. J. and Tallman J. F. (1988) Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus. Mol. Pharmacol. 33, 127-132.
26. Nishibori M., Oishi R., Itoh Y. and Saeki K. (1988) Galanin inhibits noradrenaline-induced accumulation of cyclic AMP in the rat cerebral cortex. J. Neurochem. 51, 1953-1955.
27. O'Donnell D., Ahmad S., Wahlestedt C. and Walker P. (1999) Expression of the novel galanin receptor subtype GALR2 in the adult rat CNS: distinct distribution from GALR1. J. Comp. Neurol. 409, 469-481.
28. Paxinos G. and Franklin K. B. J. (2001) The Mouse Brain in Stereotoxic Coordinates, 2nd edn. Academic Press, San Diego, CA and London.
29. Punch L. J., Self D. W., Nestler E. J. and Taylor J. R. (1997) Opposite modulation of opiate withdrawal behaviors on microinfusion of a protein kinase A inhibitor versus activator into the locus coeruleus or periaqueductal gray. J. Neurosci. 17, 8520-8527.
30. Seutin V., Verbanck P., Massotte L. and Dresse A. (1989) Galanin decreases the activity of locus coeruleus neurons in vitro. Eur. J. Pharmacol. 164, 373-376.
31. Sevcik J., Finta E. P. and Illes P. (1993) Galanin receptors inhibit the spontaneous firing of locus coeruleus neurones and interact with μ-opioid receptors. Eur. J. Pharmacol. 230, 223-230.
32. Shen P. J., Larm J. A. and Gundlach A. L. (2003) Expression and plasticity of galanin systems in cortical neurons, oligodendrocyte progenitors and proliferative zones in normal brain and after spreading depression. Eur. J. Neurosci. 18, 1362-1376.
33. Shih C. D., Chan S. H. and Chan J. Y. (1996) Participation of endogenous galanin in the suppression of baroreceptor reflex response by locus coeruleus in the rat. Brain Res. 721, 76-82.
34. Smith K. E., Walker M. W., Artymyshyn R. et al. (1998) Cloned human and rat galanin GALR3 receptors. Pharmacology and activation of G-protein inwardly rectifying K+ channels. J. Biol. Chem. 273, 23 321-23 326.
35. Suri C., Fung B. P., Tischler A. S. and Chikaraishi D. M. (1993) Catecholaminergic cell lines from the brain and adrenal glands of tyrosine hydroxylase-SV40 T antigen transgenic mice. J. Neurosci. 13, 1280-1291.
36. Sweerts B. W., Jarrott B. and Lawrence A. J. (1999) Expression of preprogalanin mRNA following acute and chronic restraint stress in brains of normotensive and hypertensive rats. Brain Res. Mol. Brain Res. 69, 113-123.
37. Tseng J. Y., Kolb P. E., Raskind M. A. and Miller M. A. (1997) Estrogen regulates galanin but not tyrosine hydroxylase gene expression in the rat locus ceruleus. Brain Res. Mol. Brain Res. 50, 100-106.
38. Tsuda K., Tsuda S., Nishio I., Masuyama Y. and Goldstein M. (1998) Effects of galanin on dopamine release in the central nervous system of normotensive and spontaneously hypertensive rats. Am. J. Hypertens. 11, 1475-1479.
39. Valentino R. J. and Aston-Jones G. (1983) Activation of locus coeruleus neurons in the rat by a benzazodne derivative (UM 1046) that mimics opiate withdrawal. Neuropharmacology 22, 1363-1368.
40. Van Hoomissen J. D., Holmes P. V., Zellner A. S., Poudevigne A. and Dishman R. K. (2004) Effects of β-adrenoreceptor blockade during chronic exercise on contextual fear conditioning and mRNA for galanin and brain-derived neurotrophic factor. Behav. Neurosci. 118, 1378-1390.
41. Waltereit R. and Weller M. (2003) Signaling from cAMP/PKA to MAPK and synaptic plasticity. Mol. Neurobiol. 27, 99-106.
42. Wang S., Hashemi T., He C., Strader C. and Bayne M. (1997) Molecular cloning and pharmacological characterization of a new galanin receptor subtype. Mol. Pharmacol. 52, 337-343.
43. Wang S., Hashemi T., Fried S., Clemmons A. L. and Hawes B. E. (1998) Differential intracellular signaling of the GalR1 and GalR2 galanin receptor subtypes. Biochemistry 37, 6711-6717.
44. Waters S. M. and Krause J. E. (2000) Distribution of galanin-1, -2 and -3 receptor messenger RNAs in central and peripheral rat tissues. Neuroscience 95, 265-271.
45. Widnell K. L., Russell D. S. and Nestler E. J. (1994) Regulation of expression of cAMP response element-binding protein in the locus coeruleus in vivo and in a locus coeruleus-like cell line in vitro. Proc. Natl Acad. Sci. USA 91, 10 947-10 951.
46. Williams J. T., Christie M. J. and Manzoni O. (2001) Cellular and synaptic adaptations mediating opioid dependence. Physiol. Rev. 81, 299-343.
47. Wittau N., Grosse R., Kalkbrenner F., Gohla A., Schultz G. and Gudermann T. (2000) The galanin receptor type 2 initiates multiple signaling pathways in small cell lung cancer cells by coupling to G(q), G(i) and G(12) proteins. Oncogene 19, 4199-4209.
48. Wynick D. and Bacon A. (2002) Targeted disruption of galanin: new insights from knock-out studies. Neuropeptides 36, 132-144.
49. Xu Z. Q., Tong Y. G. and Hokfelt T. (2001) Galanin enhances noradrenaline-induced outward current on locus coeruleus noradrenergic neurons. Neuroreport 12, 1779-1782.
50. Zachariou V., Thome J., Parikh K. and Picciotto M. R. (2000) Upregulation of galanin binding sites and GalR1 mRNA levels in the mouse locus coeruleus following chronic morphine treatments and precipitated morphine withdrawal. Neuropsychopharmacology 23, 127-137.
51. Zachariou V., Georgescu D., Kansal L., Merriam P. and Picciotto M. R. (2001) Galanin receptor 1 gene expression is regulated by cyclic AMP through a CREB-dependent mechanism. J. Neurochem. 76, 191-200.
52. Zachariou V., Brunzell D. H., Hawes J., Stedman D. R., Bartfai T., Steiner R. A., Wynick D., Langel U. and Picciotto M. R. (2003) The neuropeptide galanin modulates behavioral and neurochemical signs of opiate withdrawal. Proc. Natl Acad. Sci. USA 100, 9028-9033.